Literature DB >> 27337474

West Africa 2013: Re-examining Ebola.

Daniel G Bausch, Amanda Rojek.   

Abstract

The outbreak of Ebola virus disease (EVD) that occurred from 2013 to 2016 in the West African countries of Guinea, Liberia, and Sierra Leone, with imported cases to three neighboring African countries as well as to the United States and Europe, constituted a major humanitarian disaster. The outbreak numbered over 28,500 cases, more than 10 times the number cumulatively registered from all previous EVD outbreaks combined, with at least 11,000 deaths, and resulted in billions of dollars of lost economic growth to an already impoverished region. The unprecedented scale of West Africa 2013 took the world by surprise and laid bare deficiencies in our response capacity to complex humanitarian disasters of highly infectious and lethal pathogens. However, the magnitude of West Africa 2013 also provided an, albeit unwelcome, unique opportunity and obligation to better understand the biology and epidemiology of EVD and, equally as important, the many scientific, economic, social, political, ethical, and logistical challenges in confronting emerging diseases in the modern era. Here we re-examine EVD, reviewing the unique challenges and scientific advances of West Africa 2013, contrasting them with the prior assumptions and classical teachings, identifying what they have taught us and what we still have to learn.

Entities:  

Mesh:

Year:  2016        PMID: 27337474     DOI: 10.1128/microbiolspec.EI10-0022-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  10 in total

Review 1.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

2.  VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.

Authors:  Toni M Schwarz; Megan R Edwards; Audrey Diederichs; Joshua B Alinger; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Experimental Therapies for Ebola Virus Disease: What Have We Learned?

Authors:  Frederick G Hayden; Martin Friede; Daniel G Bausch
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

4.  Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication.

Authors:  Jyoti Batra; Judd F Hultquist; Dandan Liu; Olena Shtanko; John Von Dollen; Laura Satkamp; Gwendolyn M Jang; Priya Luthra; Toni M Schwarz; Gabriel I Small; Eusondia Arnett; Manu Anantpadma; Ann Reyes; Daisy W Leung; Robyn Kaake; Paige Haas; Carson B Schmidt; Larry S Schlesinger; Douglas J LaCount; Robert A Davey; Gaya K Amarasinghe; Christopher F Basler; Nevan J Krogan
Journal:  Cell       Date:  2018-12-13       Impact factor: 66.850

Review 5.  Ebola virus disease: Essential clinical knowledge.

Authors:  Mahmoud Tawfik Khalafallah; Omar Ali Aboshady; Shaban Ahmed Moawed; Menna Said Ramadan
Journal:  Avicenna J Med       Date:  2017 Jul-Sep

Review 6.  Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections.

Authors:  Amanda M Rojek; Peter W Horby
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

7.  Ebola virus infection induces autoimmunity against dsDNA and HSP60.

Authors:  H Fausther-Bovendo; X Qiu; S McCorrister; G Westmacott; P Sandstrom; C Castilletti; A Di Caro; G Ippolito; G P Kobinger
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

8.  Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for Diagnostics.

Authors:  Tamara L Clements; Cynthia A Rossi; Amanda K Irish; Hannah Kibuuka; Leigh Anne Eller; Merlin L Robb; Peter Kataaha; Nelson L Michael; Lisa E Hensley; Randal J Schoepp
Journal:  Open Forum Infect Dis       Date:  2019-01-03       Impact factor: 3.835

9.  Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection.

Authors:  Jyoti Batra; Hiroyuki Mori; Gabriel I Small; Manu Anantpadma; Olena Shtanko; Nawneet Mishra; Mengru Zhang; Dandan Liu; Caroline G Williams; Nadine Biedenkopf; Stephan Becker; Michael L Gross; Daisy W Leung; Robert A Davey; Gaya K Amarasinghe; Nevan J Krogan; Christopher F Basler
Journal:  EMBO J       Date:  2021-08-02       Impact factor: 14.012

10.  Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing.

Authors:  Sudip Khadka; Caroline G Williams; Joyce Sweeney-Gibbons; Christopher F Basler
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.